Abstract:Brain aging with ADNC and sporadic Alzheimer's disease (sAD) form a prevalent continuum unique to humans. Molecular changes affecting cell membranes, cytoskeleton, synapses, lipid and protein metabolism, energy metabolism, neuroinflammation, cell cycle, astrocytes, microglia, and blood vessels precede and occur in parallel with early ADNC; and they are drivers of sAD. Tau pathology is the first neuropathological hallmark but not necessarily the origin of the human brain aging with ADNC, and sAD. National Institute on Aging–Alzheimer's Association definition and classification of sporadic Alzheimer's disease (sAD) is based on the assumption that β‐amyloid drives the pathogenesis of sAD, and therefore, β‐amyloid pathology is the sine‐qua‐non condition for the diagnosis of sAD. The neuropathological diagnosis is based on the concurrence of senile plaques (SPs) and neurofibrillary tangles (NFTs) designated as Alzheimer's disease neuropathological changes. However, NFTs develop in the brain decades before the appearance of SPs, and their distribution does not parallel the distribution of SPs. Moreover, NFTs are found in about 85% of individuals at age 65 and around 97% at age 80. SPs occur in 30% at age 65 and 50%–60% at age 80. More than 70 genetic risk factors have been identified in sAD; the encoded proteins modulate cell membranes, synapses, lipid metabolism, and neuroinflammation. Alzheimer's disease (AD) overture provides a new concept and definition of brain aging and sAD for further discussion. AD overture proposes that sAD is: (i) a multifactorial and progressive neurodegenerative biological process, (ii) characterized by the early appearance of 3R + 4Rtau NFTs, (iii) later deposition of β‐amyloid and SPs, (iv) with particular non‐overlapped regional distribution of NFTs and SPs, (v) preceded by or occurring in parallel with molecular changes affecting cell membranes, cytoskeleton, synapses, lipid and protein metabolism, energy metabolism, neuroinflammation, cell cycle, astrocytes, microglia, and blood vessels; (vi) accompanied by progressive neuron loss and brain atrophy, (vii) prevalent in human brain aging, and (viii) manifested as pre‐clinical AD, and progressing not universally to mild cognitive impairment due to AD, and mild, moderate, and severe AD dementia.

Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging

Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals

Brain aging and Alzheimer's disease, a perspective from non-human primates

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies.

Distribution, progression and chemical composition of cortical amyloid-β deposits in aged rhesus monkeys: similarities to the human

Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition

β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation

Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer’s disease in nonhuman primates

Hypothesis review: Alzheimer's overture guidelines

Β‐secretase‐1 Elevation in Aged Monkey and Alzheimer’s Disease Human Cerebral Cortex Occurs Around the Vasculature in Partnership with Multisystem Axon Terminal Pathogenesis and Β‐amyloid Accumulation

Prion-like Mechanisms in Alzheimer's Disease.

Rhesus monkeys as a translational model for late‐onset Alzheimer's disease

Naturally occurring histological findings and Alzheimer's-like pathology in the brain of aging African green monkeys (Chlorocebus sabaeus)

Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease

Senile plaques and phosphorylated tau deposition in a super-aged rhesus monkey (Macaca mulatta)

The amyloid hypothesis of Alzheimer's disease at 25 years

Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer's disease and in aged nonhuman primates

Alzheimer disease-like neuropathologic changes in a geriatric baboon (Papio hamadryas)

Lack of correlation between plaque burden and cognition in the aged monkey

A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis